Accessible analytical methodology for assessing workplace contamination of antineoplastic drugs in limited-resource oncology health-care settings

Journal of Analytical Science and Technology

Table 7 Wipe sample extraction repeatability and reproducibility (precision)

Antineoplastic drug	Type of sample	Relative standard deviation (%)
Antineoplastic drug	Type of sample	Intra-day^a	Inter-day^b
Ifosfamide	LCS	1.6	1.3
	PQC	1.9	2.0
	PQC + SPE	1.7	2.1^c
Cyclophosphamide	LCS	1.4	1.9
	PQC	2.2^c	1.8
	PQC + SPE	1.5	1.7
Paclitaxel	LCS	1.5	1.8
	PQC	1.9	2.0
	PQC + SPE	1.7	2.3^c

LCS laboratory control sample, PQC performance quality control sample, SPE solid-phase extraction
^aAnalyzed on the same day (N = 3)
^bAnalyzed on five different days (N = 15)
^cValues out of acceptance criterion